These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7888154)

  • 21. [The differential diagnosis of Alzheimer's dementia from the neurological viewpoint].
    Berlit P; Hennerici M; Vetter P
    Dtsch Med Wochenschr; 1990 Nov; 115(45):1724-8. PubMed ID: 2226180
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging.
    Schmidt R
    Eur Neurol; 1992; 32(3):164-9. PubMed ID: 1592074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin cerebrospinal fluid levels in dementia.
    Molins A; Catalán R; Sahuquillo J; Castellanos JM; Codina A; Galard R
    J Neurol; 1991 Jun; 238(3):168-70. PubMed ID: 1678420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Appleyard ME; Smith AD; Berman P; Wilcock GK; Esiri MM; Neary D; Bowen DM
    Brain; 1987 Oct; 110 ( Pt 5)():1309-22. PubMed ID: 3676702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum aluminum levels in Alzheimer's disease and other senile dementias.
    Zapatero MD; Garcia de Jalon A; Pascual F; Calvo ML; Escanero J; Marro A
    Biol Trace Elem Res; 1995; 47(1-3):235-40. PubMed ID: 7779552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurosteroids: Cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics.
    Kim SB; Hill M; Kwak YT; Hampl R; Jo DH; Morfin R
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5199-206. PubMed ID: 14602750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias.
    Mecocci P; Parnetti L; Reboldi GP; Santucci C; Gaiti A; Ferri C; Gernini I; Romagnoli M; Cadini D; Senin U
    Acta Neurol Scand; 1991 Sep; 84(3):210-3. PubMed ID: 1950463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression in dementia of the Alzheimer type and in multi-infarct dementia.
    Fischer P; Simanyi M; Danielczyk W
    Am J Psychiatry; 1990 Nov; 147(11):1484-7. PubMed ID: 2221160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia.
    Spies PE; Slats D; Sjögren JM; Kremer BP; Verhey FR; Rikkert MG; Verbeek MM
    Curr Alzheimer Res; 2010 Aug; 7(5):470-6. PubMed ID: 20043812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low B12 levels related to high activity of platelet MAO in patients with dementia disorders. A retrospective study.
    Regland B; Gottfries CG; Oreland L; Svennerholm L
    Acta Psychiatr Scand; 1988 Oct; 78(4):451-7. PubMed ID: 3227965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences between Alzheimer's disease and vascular dementia on information processing measures.
    Mendez MF; Cherrier MM; Perryman KM
    Brain Cogn; 1997 Jul; 34(2):301-10. PubMed ID: 9220093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoelectric focusing and two-dimensional gel electrophoresis in plasma and cerebrospinal fluid from patients with dementia.
    Alafuzoff I; Adolfsson R; Bucht G; Jellum E; Mehta PD; Winblad B
    Eur Neurol; 1986; 25(4):285-9. PubMed ID: 3522239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical differences in senile dementia of the Alzheimer's type and in multi-infarct dementia].
    Bukatina EE; Grigor'eva IV; Smirnov OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(1):38-42. PubMed ID: 8009931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
    Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K
    Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease.
    Zaman Z; Roche S; Fielden P; Frost PG; Niriella DC; Cayley AC
    Age Ageing; 1992 Mar; 21(2):91-4. PubMed ID: 1575097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness of some neurophysiological methods in different type of dementia].
    Szyrocka-Szwed K
    Wiad Lek; 2005; 58(9-10):549-52. PubMed ID: 16529068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tau protein is a potential biological marker for normal pressure hydrocephalus.
    Kudo T; Mima T; Hashimoto R; Nakao K; Morihara T; Tanimukai H; Tsujio I; Koike Y; Tagami S; Mori H; Nakamura Y; Tanaka T; Mori K; Takeda M
    Psychiatry Clin Neurosci; 2000 Apr; 54(2):199-202. PubMed ID: 10803815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine-beta-hydroxylase activities in serum and cerebrospinal fluid of aged and demented patients.
    Miyata S; Nagata H; Yamao S; Nakamura S; Kameyama M
    J Neurol Sci; 1984 Mar; 63(3):403-9. PubMed ID: 6726279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia.
    Fredman P; Wallin A; Blennow K; Davidsson P; Gottfries CG; Svennerholm L
    Acta Neurol Scand; 1992 Feb; 85(2):103-6. PubMed ID: 1574982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.